the antiviral drug remdesivir combined with chloroquin

All this Media Hype is just that: “hype and hysteria” — just like those journalists saying that global warming will end the world in 12 years. The latest news is reassuring that we will NOT have some PANDEMIC that wipes out a substanttial number of the world population (such as the 1918 flu did).

In addition to VACCINES being developed, companies and research labs are developing old and new DRUGS — e.g. the antiviral drug remdesivir cosmbined with chloroquine appears to be effective in treating coronavirus.

A note from the editor

The novel coronavirus is moving fast — and so is the news about it.

About an hour ago, we posted this article by staff writer Laurel Oldach on new research into how the drug remdesivir (especially when combined with chloroquine) stops the coronavirus. This drug is being used in the nation’s first clinical trial of an experimental treatment for COVID-19, which is the illness caused by the SARS-CoV-2 virus. The research was published this week in the Journal of Biological Chemistry.

Now that ASBMB Today is publishing daily, we can quickly tell you what the science community is doing to learn more about SARS-CoV-2. Our writers are looking for stories the mainstream media might have missed (like the one mentioned above and John Arnst’s recent article on chloroquine), and we’re sharing articles from other science-focused journalism websites (like this one on re-creating live-animal markets in the lab).

Also, over at the JBC, Associate Editor Craig Cameron has assembled a virtual issue on coronaviruses.

We’ll continue to bring you all these stories as the outbreak runs its course — and we want to know how it is affecting the lives of ASBMB members. Are you or your colleagues doing SARS-CoV-2–related research? Is the outbreak having an impact on you personally? Are you dealing with travel restrictions or worried about loved ones? If so, please shoot us an email at

Comfort Dorn
C. Dorn
C. Dorn is the managing editor of ASBMB Today.
Remdesivir – Wikipedia

Remdesivir (development code GS-5734) is a novel antiviral drug in the class of nucleotide … The figure below is one of the synthesis route of remdesivir invented by Chun et al. from Gilead Sciences. In this method, intermediate a is firstly …

Other names‎: ‎GS-5734

Formula‎: ‎C27H35N6O8P

CAS Number‎: ‎1809249-37-3

Molar mass‎: ‎602.585 g·mol−1

‎Research usage · ‎Severe acute respiratory … · ‎Mechanism of action and … › cell research › letter to the editor

Remdesivir and chloroquine effectively inhibit the … – Nature

by M Wang – ‎2020 – ‎Cited by 24

Feb 4, 2020 – Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Manli Wang,; Ruiyuan Cao,; Leike ..

This entry was posted in Center for Environmental Genetics. Bookmark the permalink.